ArticleBMC cardiovascular disorders2025
Correlation between ApoE gene polymorphisms and the prognosis of coronary artery disease in patients undergoing percutaneous coronary intervention.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMany studies have shown that apolipoprotein E (ApoE) gene polymorphisms have an impact on coronary artery disease. However, the role of ApoE gene polymorphisms in secondary prevention is still unclear. The purpose of this study was to retrospectively investigate the influence of apolipoprotein E gene polymorphisms on the prognosis of coronary artery disease.
methodsWe collected and compared the clinical information of patients hospitalized for percutaneous coronary intervention (PCI). Multivariate hierarchical logistic regression was used to evaluate the relationship between ApoE gene polymorphisms and the prognosis of coronary artery disease in patients undergoing PCI.
resultsAfter statin treatment, the concentrations of triglycerides, LDL-C and total cholesterol significantly decreased in patients with ε3/ε4, ε3/ε3, ε2/ε3 and ε2/ε2 (p < 0.05), whereas the concentrations of triglycerides, LDL-C and total cholesterol did not significantly decrease in patients with ε4/ε4 (p > 0.05). After statin treatment, the incidence rates of hypertriglyceridemia, high LDL-C and high total cholesterol significantly decreased in patients with ε3/ε4, ε2/ε3 and ε3/ε3 (p < 0.05), whereas the incidence rates of hypertriglyceridemia, high LDL-C and high total cholesterol did not decrease significantly in patients with ε4/ε4 (p > 0.05). Multivariate logistic regression model suggested that there were no significant differences in the incidence rates of secondary PCI or in-stent restenosis in patients with different ApoE genotypes one year following PCI (p > 0.05).
conclusionAfter secondary prevention, there was no significant difference in the incidence of in-stent restenosis or secondary PCI among patients with different ApoE genotypes one year after PCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.